World's Best Scientists 2026 revealed!
Steven R. Alberts

Steven R. Alberts

D-Index & Metrics

Medicine

D-Index
87
Citations
31863
World Ranking
13538
National Ranking
6885

Overview

Steven R. Alberts is affiliated with the Mayo Clinic in the United States. Their research primarily centers on medicine, with a focus on oncology, surgery, pathology and forensic medicine, pulmonary and respiratory medicine, and cancer research. The scientist's work spans multiple facets of colorectal, gastric, pancreatic, and hepatic cancers, highlighting both treatment approaches and diagnostic advances.

The main topics of their research include:

  • Colorectal Cancer Treatments and Studies
  • Genetic factors in colorectal cancer
  • Colorectal Cancer Surgical Treatments
  • Gastric Cancer Management and Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Screening and Detection
  • Cancer Genomics and Diagnostics

Frequent co-authors collaborate with Steven R. Alberts in various studies, including:

  • Qian Shi
  • Richard M. Goldberg
  • Frank A. Sinicrope
  • Julien Taïeb
  • Greg Yothers

The scientist has published extensively in several key venues, with the highest number of publications appearing in:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • European Journal of Cancer
  • UNC Libraries
  • Cancer Epidemiology Biomarkers & Prevention

Significant recent papers exemplify the focus and scope of their research, such as:

  • "Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200," 2023, Journal of Clinical Oncology
  • "Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials," 2020, Journal of Clinical Oncology
  • "A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer," 2023, Journal of Clinical Oncology
  • "Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34,640 Patients in the ACCENT Database," 2020, JNCI Journal of the National Cancer Institute
  • "Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)," 2020, Annals of Oncology

Best Publications

  • Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

    Bruce J. Giantonio;Paul J. Catalano;Neal J. Meropol;Peter J. O'Dwyer

  • A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

    Richard M. Goldberg;Daniel J. Sargent;Roscoe F. Morton;Charles S. Fuchs

  • Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

    Sharlene Gill;Charles L. Loprinzi;Daniel J. Sargent;Stephan D. Thomé

  • Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

    Patrick J. Loehrer;Yang Feng;Higinia Cardenes;Lynne Wagner

  • Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates

    G. Folprecht;A. Grothey;S. Alberts;H.-R. Raab

  • Liver Transplantation with Neoadjuvant Chemoradiation is More Effective than Resection for Hilar Cholangiocarcinoma

    David J. Rea;Julie K. Heimbach;Charles B. Rosen;Michael G. Haddock

  • Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study

    Steven R. Alberts;William L. Horvath;William C. Sternfeld;Richard M. Goldberg

  • Gastric cancer: epidemiology, pathology and treatment

    S. R. Alberts;A. Cervantes;C. J. H. van de Velde

  • Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

    Jan Franko;Qian Shi;Charles D. Goldman;Barbara A. Pockaj

  • Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group

    Elizabeth Poplin;Yang Feng;Jordan Berlin;Mace L. Rothenberg

  • Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.

    Steven R Alberts;Daniel J Sargent;Suresh G. Nair Md;Michelle R Mahoney

  • High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200

    B. J. Giantonio;P. J. Catalano;N. J. Meropol;P. J. O'Dwyer

  • Hepatitis B-related sequelae: prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers.

    Brian J. McMahon;Steven R. Alberts;Robert B. Wainwright;Lisa Bulkow

  • SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

    Edgar Ben-Josef;Katherine A. Guthrie;Anthony B. El-Khoueiry;Christopher L. Corless

  • Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.

    Frank A. Sinicrope;Qian Shi;Thomas C. Smyrk;Stephen N. Thibodeau

  • Hepatobiliary Cancers, Version 1.2017: Featured Updates to the NCCN Guidelines

    Al B. Benson;Michael I. D'Angelica;Daniel E. Abbott;Thomas A. Abrams

  • OncoSurge: A Strategy for Improving Resectability With Curative Intent in Metastatic Colorectal Cancer

    Graeme J. Poston;René Adam;Steven Alberts;Steven Curley

  • Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

    Matthew Harold Katz;Robert Marsh;Joseph M. Herman;Qian Shi

  • Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

    Frank A. Sinicrope;Michelle R. Mahoney;Thomas C. Smyrk;Stephen N. Thibodeau

  • Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer: A North American Intergroup Trial

    Richard M. Goldberg;Daniel J. Sargent;Roscoe F. Morton;Charles S. Fuchs

Frequent Co-Authors

Richard M. Goldberg
Richard M. Goldberg West Virginia University
Thomas C. Smyrk
Thomas C. Smyrk Mayo Clinic
Axel Grothey
Axel Grothey University of Tennessee at Knoxville
Jeff A. Sloan
Jeff A. Sloan Mayo Clinic
Thierry André
Thierry André Université Paris Cité
Shaker R. Dakhil
Shaker R. Dakhil University of Kansas

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine as a career opens doors beyond the traditional MD route. Many students are choosing online programs to specialize in in-demand healthcare fields. For those interested in pharmacy, understanding online pharmacy school cost is essential, as tuition and program requirements can vary widely.

Health Information Management (HIM) is a rapidly growing area, integrating technology and patient care. Accredited him programs teach data analytics, medical law, and patient privacy fundamentals, often with flexible online options.

Another pathway is medical billing and coding. This field is accessible through online medical billing and coding courses, which prepare students to handle crucial administrative tasks for clinics and hospitals.

Nursing also offers online advanced degree opportunities. Many prospective nurse practitioners seek the cheapest np school to reduce student debt while gaining valuable clinical expertise.

Each of these options offers a unique path into healthcare, emphasizing affordability, flexibility, and career potential.

Best Scientists Citing Steven R. Alberts

Trending Scientists

Recently Published Articles